Self-Monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring.


Journal

Diabetes technology & therapeutics
ISSN: 1557-8593
Titre abrégé: Diabetes Technol Ther
Pays: United States
ID NLM: 100889084

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 14 12 2019
medline: 23 1 2021
entrez: 14 12 2019
Statut: ppublish

Résumé

Current intermittently scanned continuous glucose monitoring (isCGM) devices do not allow calibration and require confirmatory self-monitored blood glucose (SMBG) under specific defined conditions. The overall time spent in an SMBG-indicated state while using isCGM has not been reported in the existing literature. We present the time spent in an SMBG-indicated state and the daily number of transitions to an SMBG-indicated state during isCGM use in a high-risk cohort of adults with type 1 diabetes. This is a post hoc analysis of participants randomized to isCGM as part of a clinical study. The percentage of values meeting one or more of the criteria for SMBG testing (hours per day) and the number of transitions to an SMBG-indicated state per day were calculated according to the manufacturer's label in the United Kingdom. Complete data sets for 20 participants on isCGM for 8 weeks were included in the analysis. Participants spent a mean (SD) of 5.61 (1.81) h/day in an SMBG-indicated state and there were 5.43 (1.42) transitions to an SMBG-indicated state per day while using isCGM. These findings have important implications for cost-effectiveness and for decision-making around insulin dose calculations and driving. Our findings emphasize the need for continued SMBG testing among people at high risk of hypoglycemia who use isCGM. Cost-effectiveness analyses for isCGM may require revision.

Identifiants

pubmed: 31833786
doi: 10.1089/dia.2019.0369
pmc: PMC7047107
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0
Insulin 0

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

235-238

Références

Lancet. 2016 Nov 5;388(10057):2254-2263
pubmed: 27634581
Diabet Med. 2018 Apr;35(4):483-490
pubmed: 29230878
Eur Endocrinol. 2018 Sep;14(2):73-79
pubmed: 30349598
Diabetes Technol Ther. 2019 Nov 14;:
pubmed: 31724878
BMJ Open Diabetes Res Care. 2017 Apr 6;5(1):e000342
pubmed: 28611921
Diabetologia. 2019 Aug;62(8):1349-1356
pubmed: 31177314
Diabetes Res Clin Pract. 2018 Apr;138:193-200
pubmed: 29410149

Auteurs

Monika Reddy (M)

Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, United Kingdom.

Nick Oliver (N)

Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH